Kardigan, Inc.
Research Kardigan, Inc. (KARD) on Bullrun: market cap USD 1.87B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerKARD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.87B
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 56.07M
- Free cash flow-USD 59.41M
Valuation Snapshot
latest market cap is USD 1.87B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.87B | n/a | n/a | n/a |
About Kardigan, Inc.
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Kardigan, Inc.'s market cap?
Kardigan, Inc.'s market capitalization is USD 1.87B.
What does Kardigan, Inc. do?
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. It utilizes a proprietary research and development platform that integrates AI-based tools, real-world clinical data, and cardiac-specific analytics to optimize clinical study design, patient screening, and efficacy tracking.